癌症
药物发现
药品
癌细胞
GPX4
程序性细胞死亡
癌症研究
癌症治疗
脂质过氧化
抗癌药
癌症治疗
医学
生物
药理学
生物信息学
细胞凋亡
氧化应激
内科学
生物化学
过氧化氢酶
谷胱甘肽过氧化物酶
作者
Xiang Wang,Xinxin Ren,Xu Lin,Qi Li,Yingqiong Zhang,Jun Deng,Binxin Chen,Guoqing Ru,Ying Luo,Nengming Lin
标识
DOI:10.1016/j.ajps.2024.100939
摘要
Ferroptosis is a nonapoptotic form of cell death characterized by iron dependence and lipid peroxidation. Ferroptosis is involved in a range of pathological processes, such as cancer. Many studies have confirmed that ferroptosis plays an essential role in inhibiting cancer cell proliferation. In addition, a series of small-molecule compounds have been developed, including erastin, RSL3, and FIN56, which can be used as ferroptosis inducers. The combination of ferroptosis inducers with anticancer drugs can produce a significant synergistic effect in cancer treatment, and patients treated with these combinations exhibit a better prognosis than patients receiving traditional therapy. Therefore, a thorough understanding of the roles of ferroptosis in cancer is of great significance for the treatment of cancer. This review mainly elaborates the molecular biological characteristics and mechanism of ferroptosis, summarizes the function of ferroptosis in cancer development and treatment,illustrates the application of ferroptosis in patient's prognosis prediction and drug discovery, and discusses the prospects of targeting ferroptosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI